 It was approved in the US in 2011 under the FDA's accelerated approval program.An investigation commissioned by the Canadian Association of University Teachers (CAUT) revealed that one of Olivieri's critics, Gideon Koren, had anonymously sent disparaging letters about Olivieri to the media and colleagues.Koren initially denied responsibility, but substantial DNA evidence tied him to the letters, and he was reprimanded.